MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. (2017)

First Author: Kerry J
Attributed to:  MRC Wellcome Trust Human Developmental Biology Resource (HDBR) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2016.12.054

PubMed Identifier: 28076791

Publication URI: http://europepmc.org/abstract/MED/28076791

Type: Journal Article/Review

Volume: 18

Parent Publication: Cell reports

Issue: 2